Overexpression of CD44 Variant 9: A Novel Cancer Stem Cell Marker in Human Cholangiocarcinoma in Relation to Inflammation
Various CD44 isoforms are expressed in several cancer stem cells during tumor progression and metastasis. In particular, CD44 variant 9 (CD44v9) is highly expressed in chronic inflammation-induced cancer. We investigated the expression of CD44v9 and assessed whether CD44v9 is a selective biomarker o...
Saved in:
| Main Authors: | Nattawan Suwannakul, Ning Ma, Raynoo Thanan, Somchai Pinlaor, Piti Ungarreevittaya, Kaoru Midorikawa, Yusuke Hiraku, Shinji Oikawa, Shosuke Kawanishi, Mariko Murata |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2018/4867234 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nuclear Localization of COX-2 in relation to the Expression of Stemness Markers in Urinary Bladder Cancer
by: Raynoo Thanan, et al.
Published: (2012-01-01) -
DNA Damage in CD133-Positive Cells in Barrett’s Esophagus and Esophageal Adenocarcinoma
by: Raynoo Thanan, et al.
Published: (2016-01-01) -
Inflammation-Related DNA Damage and Cancer Stem Cell Markers in Nasopharyngeal Carcinoma
by: Shumin Wang, et al.
Published: (2016-01-01) -
Proteomics detection of S100A6 in tumor tissue interstitial fluid and evaluation of its potential as a biomarker of cholangiocarcinoma
by: Sudarat Onsurathum, et al.
Published: (2018-04-01) -
Upregulation of transferrin receptor-1 induces cholangiocarcinoma progression via induction of labile iron pool
by: Wassana Jamnongkan, et al.
Published: (2017-07-01)